The Integrated Islet Distribution Program (IIDP) funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), replaces the NCRR and JDRF funded National Islet Cell Resource Consortium which ended July 31, 2009. The IIDP continues to provide islet availability for fundamental research. As Chair, Department of Diabetes & Cancer Discovery Science, Diabetes and Metabolism Research Institute at City of Hope, Joyce C. Niland, Ph.D. serves as Principal Investigator (PI) for this grant.
The IIDP consists of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Program Officers, an External Scientific Panel, and the Coordinating Center at City of Hope. The IIDP integrates an interactive group of islet isolation centers to coordinate the distribution of human islets. The IIDP Coordinating Center is responsible for broadcasting the availability of human islets to investigators worldwide.
All investigators requesting islets must complete and submit an application to the IIDP Coordinating Center. In addition to the completed application form, applicants must also submit a concise but thorough and informative description of the specific objectives, methods associated with the use of islets, rationale for the number of islets requested and statistical methodologies to be employed. Click here for information on how to reference the obtaining islets for your grant.
For inclusion within grant application:
Human Pancreatic Islets for Experimentation
Human pancreatic islets are obtained through
the NIDDK-funded Integrated Islet Distribution Program (IIDP; see https://iidp.coh.org/),
on a subscription fee basis. The IIDP works with leading islet isolation centers in the U.S. to distribute high quality human islets to the diabetes research community. Fees are based on number of islets needed at a rate of $0.12/IEQ. You can subscribe for any number of islets you need and can re-subscribe at any time.